View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. Technical Analysis for CBAY - CymaBay Therapeutics Inc. Quote; Chart; End-of-Day Trading Signals; Intraday Alerts; Profile; Buy or Sell? News; Discussion ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Research CymaBay Therapeutics' (Nasdaq:CBAY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance …Aug 2, 2023 · Fintel reports that on August 14, 2023, UBS initiated coverage of Cymabay Therapeutics (NASDAQ:CBAY) with a Buy recommendation.. Analyst Price Forecast Suggests 15.86% Upside. As of August 2, 2023 ...CBAY - CymaBay Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) ... CymaBay Therapeutics, Inc. (US:CBAY) has 420 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 132,650,878 shares.Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis. CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... Realtime quote and/or trade prices are not sourced from all markets. Nov 14, 2023 · This strengthens the case for CBAY’s potential in the rapidly expanding PBC therapeutics market. In another report released today, Piper Sandler also maintained a Buy rating on the stock with a ... CBAY, for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the …Based on analysts projections #CBAY is expected to experience a price decline over the next year. The current average CBAY price target, as estimated by these analysts, is $0.00.. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.. It is important to …Real-time Price Updates for Cymabay Therapeutics (CBAY-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreWith stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Discover real-time eBay Inc. Common Stock (EBAY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.What's Happening with CBAY Stock Today CymaBay Therapeutics Inc (CBAY) stock is up 2.44% while the S&P 500 has risen 0.75% as of 12:15 PM on Thursday, Dec 7. CBAY has risen $0.51 from the previous closing price of $20.86 on volume of 582,850 shares. Over the past year the S&P 500 has risen 16.51% while CBAY has risen …Shares of CBAY surged 25.8% on the acquisition news as the offer price represents 27% of the company’s closing share price as of Feb 9, 2024. Financial Terms of the AcquisitionBased on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67. 1 day ago · If yes, then on this page you will find useful information about the dynamics of the CBAY stock price in 2022-2027. Is CBAY a good long term stock? When should I take profit in Cymabay Therapeutics stock? Buy or sell stock? Will CBAY stock price go up? What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using ...Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC …Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-8800Sep 9, 2023 ... ON THE VERGE OF BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK ... PRICE BREAKOUT : MFC STOCK ANALYSIS | MANULIFE FINANCIAL STOCK.View CymaBay Therapeutics (NASDAQ:CBAY) historical prices, past price performance, and an advanced CBAY stock chart at MarketBeat.Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Jun 30, 2023 ... The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced phase 3 trials data for elafibranor to treat the rare autoimmune ...View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. Is Cymabay Therapeutics (NASDAQ:CBAY) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Last updated Sunday February 18th 1:06pmThe CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...Cymabay Therapeutics (CBAY) Stock Price Performance. Cymabay Therapeutics (CBAY) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. ... Realtime quote and/or trade prices are not sourced from all markets.BETS. Bit Brother Limited Class A Ordinary Shares. $6.63 +0.83 +14.31%. CymaBay Therapeutics Inc. Common Stock (CBAY) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data ...The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Stock Price Statistics The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. Learn more on ...View the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …Insider Sell: CymaBay Therapeutics Inc President of R&D Charles Mcwherter Sells 18,403 Shares. Charles Mcwherter, President of R&D at CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 18,403 shares of the company on January 19, 2024, according to a recent SEC Filing. GuruFocus.com.CBAY price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 11.17x. Industry. 5.88x. ... Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...Nasdaq. 15,942.59 +148.88 ... Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late-stage RESPONSE study.Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sep 9, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC …CymaBay Therapeutics Stock Earnings. The value each CBAY share was expected to gain vs. the value that each CBAY share actually gained. CymaBay Therapeutics ( CBAY) reported Q3 2023 earnings per share (EPS) of -$0.32, missing estimates of -$0.29 by 10.04%. In the same quarter last year, CymaBay Therapeutics 's earnings per share (EPS) was -$0.28. Analyst Price Target for CBAY i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).Capital Small Share Price: Find the latest news on Capital Small Stock Price. Get all the information on Capital Small with historic price charts for NSE / BSE. Experts …Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Shares of CBAY surged 25.8% on the acquisition news as the offer price represents 27% of the company’s closing share price as of Feb 9, 2024. Financial Terms of the AcquisitionWhat happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...Find the latest CBAY240216C00034000 (CBAY240216C00034000) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...4 days ago · CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73 Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.CBAY has fallen -$0.10 from the previous closing price of $22.85 on volume of 483,390 shares. Over the past year the S&P 500 has gained 21.52% while CBAY has gained 191.67%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating Based on 13 analysts giving stock ratings to CBAY in the past 3 months.CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73Feb 9, 2024 · Currently, NASDAQ:CBAY has a 10 as its setup rating: CBAY has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 24.97. Right above this resistance zone may be a good entry point.Stock Price Forecast. The 10 analysts with 12-month price forecasts for CBAY stock have an average target of 24.1, with a low estimate of 15 and a high estimate of 34. The average target predicts a decrease of …Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Stock Price Forecast. The 10 analysts with 12-month price forecasts for CBAY stock have an average target of 24.1, with a low estimate of 15 and a high estimate of 34. The average target predicts a decrease of …Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ...Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 3,652,614 Shares Outstanding, K 113,400 …The average twelve-month price prediction for CymaBay Therapeutics is $23.70 with a high price target of $34.00 and a low price target of $12.00. Learn more …3 days ago · A. The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by LifeSci Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 0.00 expecting CBAY to ... 5 days ago · Get CymaBay Therapeutics Inc (CBAY.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments The last closing price of CBAY's stock was USD 25.69. What is the market value of Cymabay Therapeu? The most recent market capitalization for CBAY is USD 2.34B. Will Cymabay Therapeu stock go up ? Based on targets from 9 analysts, the average taret price for CBAY is projected at USD 23.77 over the next 12 months. This means that CBAY's …Find out if CymaBay Therapeutics Inc (CBAY:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Quickest stock price recoveries post dividend payment. This trading strategy invovles purchasing a stock just before the ex-dividend date in order to collect the dividend and then selling after the stock price has recovered. High Yield ... CBAY | stock. $23.82-2.34%. $2.68 B. 0.00%. $0.00-Get the latest CymaBay Therapeutics, Inc. (CBAY) stock news and headlines to help you in your trading and investing decisions. Research CymaBay Therapeutics' (Nasdaq:CBAY) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst CBAY forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...Find the latest CBAY240216C00034000 (CBAY240216C00034000) stock quote, history, news and other vital information to help you with your stock trading and investing.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Research CymaBay Therapeutics' (Nasdaq:CBAY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance …The CymaBay Therapeutics stock forecast for tomorrow is $ 25.72, which would represent a 0.13% gain compared to the current price. In the next week, the price of CBAY is expected to decrease by -2.50% and hit $ 25.05.. As far as the long-term CymaBay Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.View the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday.Feb 13, 2024 · Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.
CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... . Foil math
Dec 18, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 ...Jan 14, 2024 · CBAY Historical Data. ... Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR ...CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $32.18 -0.02 (-0.06%) (As of 02/16/2024 ET) Compare Today's Range $32.12 $32.19 50-Day Range …Get the latest stock price, news and history of CymaBay Therapeutics Inc. Common Stock (CBAY), a biotechnology company developing treatments for neurological disorders. See …Nov 8, 2023 · CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...MoonLake Immunotherapeutics. 63.19. +1.94. +3.17%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. CBAY has gained $0.28 from the previous closing price of $23.71 on volume of 535,102 shares. Over the past year the S&P 500 is higher by 23.21% while CBAY has gained 302.52%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. CymaBay Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CBAY stock price. Find the latest eBay Inc. (EBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. .
Popular Topics
- E minor chordSanofi share price
- Happy happy happy songNick mcglashan
- Summer rental filmStarmarket near me
- 2024 toyota tacoma interiorLamberto quintero letra
- Closer look seth meyersHarry styles harrys house
- Alan jackson livin on loveExtreme car driving simulator 2023 online
- Cheap student flightsEl salvador vs usa